Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Evaluation of Immunization Against Tumor Cells in Subjects With Sezary Syndrome Using Autologous Mature Dendritic Cells

NCT00099593 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00099593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00099593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Evaluation of Immunization Against Tumor Cells in Subjects With Sezary Syndrome Using Autologous Mature Dendritic Cells
Lead sponsor
University of Pittsburgh
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
September 30, 2007
Enrollment
17 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous t-cell lymphoma, sezary syndrome